Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,014 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

NCT02085161

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • Boehringer Ingelheim Investigational Site Torrance, California, United States
  • Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • Boehringer Ingelheim Investigational Site Daw Park, South Australia, Australia
View all 34 locations
View Trial Details
Completed

Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)

NCT00970268

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1162 Birmingham, Alabama, United States
  • Forest Investigative Site 1127 Mobile, Alabama, United States
  • Forest Investigative Site 0909 Glendale, Arizona, United States
  • Forest Investigative Site 2060 Phoenix, Arizona, United States
View all 83 locations
View Trial Details
Completed

A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00500318

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +16 more
Locations
  • Forest Investigative Site 2088 Jasper, Alabama, United States
  • Forest Investigative Site 0909 Phoenix, Arizona, United States
  • Forest Investigative Site 0957 Long Beach, California, United States
  • Forest Investigative Site 0973 Los Angeles, California, United States
View all 52 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

NCT00891462

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site Birmingham, Alabama, United States
  • Forest Investigative Site Jasper, Alabama, United States
  • Forest Investigative Site Mobile, Alabama, United States
  • Forest Investigative Site Mesa, Arizona, United States
View all 112 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01462929

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Site #9 Humpolec, Czechia
  • Almirall Investigational Site #1 Jaroměř, Czechia
  • Almirall Investigational Site #3 Mělník, Czechia
  • Almirall Investigational Site #4 Berlin, Germany
View all 41 locations
View Trial Details
Completed

Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)

NCT00358436

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#926 Jasper, Alabama, United States
  • Almirall Investigational Sites#858 Ozark, Alabama, United States
  • Almirall Investigational Sites#900 Phoenix, Arizona, United States
  • Almirall Investigational Sites#899 Tucson, Arizona, United States
View all 120 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide 400 µg BID (Twice a Day)Compared to Placebo in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT01471171

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Site #10 Berlin, Germany
  • Almirall Investigational Site #6 Berlin, Germany
  • Almirall Investigational Site #2 Berlin, Germany
  • Almirall Investigational Site #4 Frankfurt, Germany
View all 14 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01001494

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#4 Benešov, Czechia
  • Almirall Investigational Sites#9 Jaroměř, Czechia
  • Almirall Investigational Sites#3 Liberec, Czechia
  • Almirall Investigational Sites#2 Lovosice, Czechia
View all 106 locations
View Trial Details

Related conditions